tiprankstipranks
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
US Market
VRDN
Viridian Therapeutics
RESEARCH TOOLSreports
Want to see VRDN full AI Analyst Report?

Viridian Therapeutics (VRDN) Stock News & Sentiment

1,521 Followers
Viridian Therapeutics: REVEAL-2 Success and Strong Cash Runway Support Buy Rating, $32 Price Target Unchanged
Premium
Ratings
Viridian Therapeutics: REVEAL-2 Success and Strong Cash Runway Support Buy Rating, $32 Price Target Unchanged
10h ago
VRDN
Analyst Reiterates Buy as Strong Phase III REVEAL-2 Data Boost Elegrobart’s Regulatory and Commercial Outlook
Premium
Ratings
Analyst Reiterates Buy as Strong Phase III REVEAL-2 Data Boost Elegrobart’s Regulatory and Commercial Outlook
14h ago
VRDN
Viridian Reports Positive Phase 3 Results in Thyroid Eye Disease
Premium
Company Announcements
Viridian Reports Positive Phase 3 Results in Thyroid Eye Disease
18h ago
8K
VRDN
Viridian: Dual TED Franchise Catalysts Support Favorable Risk‑Reward and Buy Rating
Premium
Ratings
Viridian: Dual TED Franchise Catalysts Support Favorable Risk‑Reward and Buy Rating
16d ago
VRDN
3 Best Trending Stocks, According to Analysts – 4/7/2026
Premium
Market News
3 Best Trending Stocks, According to Analysts – 4/7/2026
29d ago
AMGN
NBIX
Viridian: Pullback Seen as Overdone as Veligrotug Convenience and TED Portfolio Underscore Buy Rating
Premium
Ratings
Viridian: Pullback Seen as Overdone as Veligrotug Convenience and TED Portfolio Underscore Buy Rating
29d ago
VRDN
Buy Rating on Viridian: Elegrobart’s Convenience Edge and Overdone Share Price Pullback in Thyroid Eye Disease
Premium
Ratings
Buy Rating on Viridian: Elegrobart’s Convenience Edge and Overdone Share Price Pullback in Thyroid Eye Disease
30d ago
VRDN
More VRDN News >

VRDN News on the Web

Viridian: Dual TED Franchise Catalysts Support Favorable Risk‑Reward and Buy Rating
TipRanks News
Bullish
Viridian Therapeutics price target lowered to $24 from $32 at Evercore ISI
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (ELVN), Viridian Therapeutics (VRDN) and Soleno Therapeutics (SLNO)
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (MDT) and Viridian Therapeutics (VRDN)
TipRanks News
Neutral
Viridian Therapeutics price target lowered to $36 from $40 at Truist
TipRanks News
Bearish
Viridian Therapeutics price target lowered to $31 from $37 at Wedbush
TipRanks News
Bearish
3 Best Trending Stocks, According to Analysts – 4/7/2026
TipRanks News
Bullish
Viridian Therapeutics price target lowered to $30 from $42 at RBC Capital
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
VRDN
Sector Average
Media Buzz
This Week1 articles
Weekly Average15.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VRDN’s Media Buzz Sentiment?
1 articles about VRDN were published this week. In an average week, 15.25 articles are published.
    What is VRDN’s weekly average amount of articles?
    In an average week, 15.25 articles about VRDN are published.
      What is VRDN’s News Sentiment?
      100% of articles about VRDN were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week